Quinine-induced renal failure as a result of rhabdomyolysis, haemolytic uraemic syndrome and disseminated intravascular coagulation

Internal Medicine Journal

Volumn 36, Issue 7, 2006, Pages 465-467

  Lim, A K H ^a   Ho, L ^a   Levidiotis, V ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Atorvastatin; Cytochrome P450; Disseminated intravascular coagulation; Haemolytic uraemic syndrome; Quinine; Rhabdomyolysis

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ATENOLOL; ATORVASTATIN; CEFTRIAXONE; GLUCOSAMINE; QUININE; THROMBOCYTE ANTIBODY;

ABDOMINAL PAIN; ACUTE HEPATITIS; ACUTE KIDNEY FAILURE; ADULT; ANEMIA; ARTICLE; BACKACHE; BLOOD CLOTTING DISORDER; CASE REPORT; CHOLECYSTECTOMY; CHRONIC PAIN; DIARRHEA; DISSEMINATED INTRAVASCULAR CLOTTING; DIZZINESS; DRUG ERUPTION; DRUG FEVER; DYSLIPIDEMIA; ECG ABNORMALITY; ERYTHROCYTE DISORDER; FEMALE; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; HYPOTENSION; LEG CRAMP; MYALGIA; NAUSEA; NECK PAIN; PARESTHESIA; PRIORITY JOURNAL; RHABDOMYOLYSIS; RIGOR; SEPSIS; T WAVE INVERSION; TACHYCARDIA; TACHYPNEA; THORAX PAIN; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VOMITING;

ANTICHOLESTEREMIC AGENTS; DISSEMINATED INTRAVASCULAR COAGULATION; DRUG SYNERGISM; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HEPTANOIC ACIDS; HUMANS; KIDNEY FAILURE, ACUTE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; PYRROLES; QUININE; RHABDOMYOLYSIS; SLEEP-WAKE TRANSITION DISORDERS;

EID: 33745049018     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01104.x     Document Type: Article

References (9)

1. Adverse Drug Reactions Advisory Committee (ADRAC) database 1972-24 August 2005 Search requests can be made through the Adverse Drug Reactions Unit : adrac@health.gov.au MT Bowton DL Owen J Dunagan DP. Quinine-induced disseminated intravascular coagulation: case report and review of the literature. Intensive Care Med 2003 29 : 1007 11.
2. Kojouri K Vesely S George J. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med 2001 135 : 1047 51.
3. Medina PM Sipols JM George JN. Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol 2001 8 : 286 93.
4. Gottschall JL Neahring B McFarland JG Wu GG Weitekamp LA Aster RH. Quinine-induced immune thrombocytopenia with haemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature. Am J Hematol 1994 47 : 283 9.
5. Spearing RL Hickton CM Sizeland P Hannah A Bailey RR. Quinine-induced disseminated intravascular coagulation. Lancet 1990 336 : 1535 7.
6. Lennernas H. Clinical pharmacokinetics of atorvastatin. Clin Pharmacokinet 2003 42 : 1141 60.
7. Paine MF Khalighi M Fisher JM Shen DD Kunze KL Marsh CL et al. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther 1997 283 : 1552 62.
8. Jacobson TA. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors. Am J Cardiol 2004 94 : 1140 6.
9. Michalets EL. Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy 1998 18 : 84 112.